2 studies on Mmp inhibition mechanism curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
**Topical GHK-Cu meaningfully outperforms both untreated control and vehicle alone in ischemic conditions**, which is the relevant clinical scenario for chronic wounds in humans. The dual action — accelerated closure …
**A reproducible 6-hour lag time positions this formulation as a viable oral colon-targeted delivery vehicle for GHK-Cu2+**, a peptide that would otherwise be digested or absorbed before reaching inflamed colonic muco…